KIDNEY NEOPLASMS
Clinical trials for KIDNEY NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new KIDNEY NEOPLASMS trials appear
Sign up with your email to follow new studies for KIDNEY NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare kidney cancer: targeted drug savolitinib faces off against standard therapy
Disease control OngoingThis phase 3 study compares a new drug, savolitinib, to the standard drug sunitinib in 60 people with a specific type of advanced kidney cancer called MET-driven papillary renal cell carcinoma. The goal is to see if savolitinib is better at stopping the cancer from growing and to…
Matched conditions: KIDNEY NEOPLASMS
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New MRI method may spare kidney patients unnecessary biopsies
Diagnosis OngoingThis study tests whether a special MRI can tell the difference between harmless and cancerous kidney growths when standard CT scans cannot see fat. About 44 adults with kidney masses that have no visible fat on CT will get this advanced MRI. The goal is to see if the MRI can iden…
Matched conditions: KIDNEY NEOPLASMS
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC